Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Vermeulen, Jeroen F ^a   Kornegoor, Robert ^a   van der Wall, Elsken ^a   van der Groep, Petra ^a   van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII; CD44V6 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLUCOSE TRANSPORTER 1; SOMATOMEDIN C RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; ENZYME ACTIVITY; FEMALE; GYNECOMASTIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR IMAGING; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; BREAST NEOPLASMS, MALE; CARBONIC ANHYDRASES; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 1; GYNECOMASTIA; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MOLECULAR IMAGING; RECEPTORS, GROWTH FACTOR; SEX FACTORS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871911222     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053353     Document Type: Article

References (39)

1. Miao H, Verkooijen HM, Chia KS, Bouchardy C, Pukkala E, et al. (2011) Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol 29: 4381-4386.
2. Anderson WF, Jatoi I, Tse J, Rosenberg PS, (2010) Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 28: 232-239.
3. Fentiman IS, Fourquet A, Hortobagyi GN, (2006) Male breast cancer. Lancet 367: 595-604.
4. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN, (2004) Breast carcinoma in men: a population-based study. Cancer 101: 51-57.
5. Shaaban AM, Ball GR, Brannan RA, Cserni G, Di Benedetto A, et al. (2012) A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat 133: 949-958.
6. Ge Y, Sneige N, Eltorky MA, Wang Z, Lin E, et al. (2009) Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res 11: R28.
7. Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, et al. (2012) Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol 25: 398-404.
8. Ciocca V, Bombonati A, Gatalica Z, Di Pasquale M, Milos A, et al. (2006) Cytokeratin profiles of male breast cancers. Histopathology 49: 365-370.
9. Moore J, Friedman MI, Gansler T, Gramlich TL, Derose PB, et al. (1998) Prognostic indicators in male breast carcinoma. Breast J 4: 261-269.
10. Foerster R, Foerster FG, Wulff V, Schubotz B, Baaske D, et al. (2011) Matched-pair analysis of patients with female and male breast cancer: a comparative analysis. BMC Cancer 11: 335.
11. Willsher PC, Leach IH, Ellis IO, Bell JA, Elston CW, et al. (1997) Male breast cancer: pathological and immunohistochemical features. Anticancer Res 17: 2335-2338.
12. Fox SB, Rogers S, Day CA, Underwood JC, (1992) Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma. J Pathol 166: 13-18.
13. Pivot X, Bedairia N, Thiery-Vuillemin A, Espie M, Marty M, (2011) Combining molecular targeted therapies: clinical experience. Anticancer Drugs 22: 701-710.
14. Valachis A, Mauri D, Polyzos NP, Chlouverakis G, Mavroudis D, et al. (2011) Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis. Breast 20: 485-490.
15. Garrett CR, Eng C, (2011) Cetuximab in the treatment of patients with colorectal cancer. Expert Opin Biol Ther 11: 937-949.
16. Brockstein BE, (2011) Management of recurrent head and neck cancer: recent progress and future directions. Drugs 71: 1551-1559.
17. Sampath L, Kwon S, Ke S, Wang W, Schiff R, et al. (2007) Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 48: 1501-1510.
18. Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, et al. (2008) Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res 14: 3840-3849.
19. Gee MS, Upadhyay R, Bergquist H, Alencar H, Reynolds F, et al. (2008) Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology 248: 925-935.
20. Pleijhuis RG, Graafland M, de Vries J, Bart J, de Jong JS, et al. (2009) Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol 16: 2717-2730.
21. Pleijhuis RG, Langhout GC, Helfrich W, Themelis G, Sarantopoulos A, et al. (2011) Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg Oncol 37: 32-39.
22. Hirche C, Murawa D, Mohr Z, Kneif S, Hunerbein M, (2010) ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 121: 373-378.
23. Crane LM, Themelis G, Arts HJ, Buddingh KT, Brouwers AH, et al. (2011) Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol 120: 291-295.
24. Vermeulen JF, van Brussel AS, van der Groep P, Morsink FH, Bult P, et al. (2012) Immunophenotyping invasive breast cancer: paving the road for molecular imaging. BMC Cancer 12: 240.
25. Vermeulen JF, van de Ven RA, Ercan C, van der Groep P, van der Wall E, et al. (2012) Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer. PLoS One 7: e37864.
26. Elston CW, Ellis IO, (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410.
27. van der Groep P, Bouter A, van der Zanden R, Siccama I, Menko FH, et al. (2006) Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 59: 611-617.
28. Kornegoor R, Verschuur-Maes AH, Buerger H, van Diest PJ, (2012) The 3-layered ductal epithelium in gynecomastia. Am J Surg Pathol 36: 762-768.
29. CCMO website: Central Committee on Research involving Human Subjects (Centrale Commissie Mensgebonden Onderzoek) (text in Dutch). Available: http://www.ccmo-online.nl/main.asp?pid=10&sid=30&ssid=51. Accessed: 2012 Oct 1.
30. van Diest PJ, (2002) No consent should be needed for using leftover body material for scientific purposes. For. BMJ 325: 648-651.
31. Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, et al. (2012) Fibrotic focus and hypoxia in male breast cancer. Mod Pathol 25: 1397-1404.
32. Peyrat JP, Bonneterre J, Beuscart R, Djiane J, Demaille A, (1988) Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 48: 6429-6433.
33. Stoll BA, (2002) Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications. Ann Oncol 13: 191-196.
34. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, et al. (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4: e1000054.
35. Bane AL, Pinnaduwage D, Colby S, Reedijk M, Egan SE, et al. (2009) Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors. Breast Cancer Res Treat 117: 183-191.
36. Gethins M, (2012) Breast cancer in men. J Natl Cancer Inst 104: 436-438.
37. Evans DG, Susnerwala I, Dawson J, Woodward E, Maher ER, et al. (2010) Risk of breast cancer in male BRCA2 carriers. J Med Genet 47: 710-711.
38. Barnett DH, Sheng S, Charn TH, Waheed A, Sly WS, et al. (2008) Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res 68: 3505-3515.
39. Wykoff CC, Beasley N, Watson PH, Campo L, Chia SK, et al. (2001) Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158: 1011-1019.